CNS Pharmaceuticals (CNSP) Cash from Investing Activities Growth (1y) (2020 - 2024)

CNS Pharmaceuticals (CNSP) Cash from Investing Activities Growth (1y) (2020 - 2024) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Investing Growth (1y) (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	90.55%
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	91.53%
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-41.67%
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	25.90%
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-157.08%
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-589.38%
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-89.24%
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	26.37%
10	CNS Pharmaceuticals	2.65 Mn	-4.55 Mn	-	-

Download Data